Summary
The presence of β-endorphin and enkephalin in pancreatic islets suggests that opioid peptides may play a role in the regulation of pancreatic endocrine function. Since data in the literature are rather controversial, we examined the effects of different doses of naloxone on insulin and glucagon secretion in 21 healthy nonobese volunteers (6 women and 15 men) by measuring the variations of insulin and glucagon plasma levels following a 5-g i.v. glucose load before and during a 30-min naloxone infusion. Total amounts of 0.4 and 0.8 mg of naloxone failed to modify serum insulin and plasma glucose responses to glucose challenge. On the contrary, 0.2 mg/kg (i.e. 12–14 mg per subject as total amount) given to 3 women and 6 men led to a glucose-induced insulin release significantly lower than that recorded in basal conditions, with corresponding greater plasma glucose elevation. The suppressive effect of glucose on glucagon concentration was less pronounced during naloxone. Data reported here suggest that inhibition of opiate receptors in human pancreas occurs only with large amounts of naloxone. Moreover, they may indirectly support the stimulatory role of opioid peptides on insulin secretion in man, according to some experimentalin vitro andin vivo studies. In addition, naloxone seems to reduce pancreatic A-cell sensitivity to hyperglycemia.
Similar content being viewed by others
References
Bruni J. F., Watkins W. B., Yen S. S. C.: β-endorphin in the human pancreas — J. clin. Endocrinol.49, 649, 1979.
Chang K.-J., Cuatrecasas P.: Heterogeneity and properties of opiate receptors — Fed. Proc.40, 2729, 1981.
Cuello A. C.: Endogenous opioid peptides in neurons of the human brain — Lancetii, 291, 1978.
Feldman M., Kiser R. S., Unger R. H., Li C. H.: Beta-endorphin and the endocrine pancreas — New Engl. J. Med.308, 349, 1983.
Giugliano D., Ceriello A., Di Pinto P., Saccomanno F., Gentile S., Cappiapuoti F.: Impaired insulin secretion in human diabetes mellitus. The effects of naloxone-induced opiate receptor blockade — Diabetes31, 367, 1982.
Ipp E., Dobbs R., Unger R. H.: Morphine and β-endorphin influence the secretion of the endocrine pancreas — Nature (Lond.)276, 190, 1978.
Kanter R. A., Ensinck J. W., Fujimoto W. Y.: Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures — Diabetes29, 84, 1980.
Leslie R. D. G., Pyke D. A., Stubbs W. A.: Sensitivity to an enkephalin as a cause of non-insulin-dependent diabetes mellitus — Lanceti, 341, 1979.
Morley J. E., Baranetsky N. G., Wingert T. D., Carlson H. E., Hershman J. M., Melmed S., Levin S. R., Jamison K. R., Weitzman R., Chang R. J., Varner A. A.: Endocrine effects of naloxone-induced opiate receptor blockade — J. clin. Endocrinol.50, 251, 1980.
Pierluissi R., Pierluissi J., Ashcroft S. J. H.: Effects of an enkephalin analogue (DAMME) on insulin release from cultured rat islets of Langerhans — Diabetologia20, 642, 1981.
Polak J. M., Sullivan S. N., Bloom S. R., Facer P., Pearse A. G. E.: Enkephalin-like immunoreactivity in the human gastrointestinal tract — Lanceti, 972, 1977.
Reid R. L., Yen S. S. C.: β-endorphin stimulates the secretion of insulin and glucagon in humans — J. clin. Endocrinol.52, 592, 1981.
Shaar C. J., Frederickson R. C. A., Dininger N. B., Jackson L.: Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin. Evidence for regulation by endogenous opioid peptide in brain — Life Sci.21, 853, 1977.
Shaffer Tannembaum G., Panerai A. E., Friesen H. G.: Failure of β-endorphin antiserum, naloxone and naltrexone to alter physiologic growth hormone and insulin secretion — Life Sci.25, 1983, 1979.
Stubbs W. A., Delitala G., Jones A., Jeffcoate W. J., Edwards C. R. W., Ratter S. J., Besser G. M., Bloom S. R., Alberti K. G. M. M.: Hormonal and metabolic responses to an enkephalin analogue in normal man — Lancetii, 1225, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Locatelli, A., Spotti, D. & Caviezel, F. The regulation of insulin and glucagon secretion by opiates: A study with naloxone in healthy humans. Acta diabet. lat 22, 25–31 (1985). https://doi.org/10.1007/BF02591089
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02591089